2010
DOI: 10.2174/1874827901003010001
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive Dimensions in Alzheimer`s Disease, Mild Cognitive Impairment, and Normal Elderly: Developing a Common Metric~!2009-11-20~!2010-02-01~!2010-03-12~!

Abstract: Abstract:The aim of this research was to assess similarity in cognitive factor structures underlying neuropsychological test performance of elders belonging to three clinical groups: Alzheimer's disease (AD), Mild Cognitive Impairment (MCI), and normal elderly. We administered a battery of neuropsychological tests to 214 elderly participants in the groups. First, the underlying cognitive structure of a Combined-Set of AD, MCI, and Control subjects was determined by Principal Components Analysis (PCA), includin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 42 publications
(42 reference statements)
0
11
0
Order By: Relevance
“…We developed a common metric for all the clinical groups of interest by using all of their data in the PCA, believing it would be a stronger measurement tool because it reflected both individual and, more importantly for discrimination, group differences. Also, including impaired and normal individuals in the PCA ensures that components best able to differentiate between the groups will appear in the component structure (Chapman et al, 2009). Methodologically, using a variety of groups in the development of the underlying structure would tend to avoid the one-group risk of restricting the range in the test measures and thereby attenuating correlations among variables that can result in falsely low estimates of component loadings (Fabrigar, MacCullum, Wegener, & Stahan, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…We developed a common metric for all the clinical groups of interest by using all of their data in the PCA, believing it would be a stronger measurement tool because it reflected both individual and, more importantly for discrimination, group differences. Also, including impaired and normal individuals in the PCA ensures that components best able to differentiate between the groups will appear in the component structure (Chapman et al, 2009). Methodologically, using a variety of groups in the development of the underlying structure would tend to avoid the one-group risk of restricting the range in the test measures and thereby attenuating correlations among variables that can result in falsely low estimates of component loadings (Fabrigar, MacCullum, Wegener, & Stahan, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…First, increasing the number of observations added stability to the resultant structure. Second, including a variety of subject groups in the creation of the component structure allowed for greater generalizability to the population (Chapman, Mapstone, McCrary et al, 2010; John, Easton, Prichep, & Friedman, 1993). Using data from only one group also would risk restricting the range in the test measures and attenuating correlations among variables that could result in falsely low estimates of component loadings (Fabrigar, MacCullum, Wegener, & Stahan, 1999).…”
Section: Methodsmentioning
confidence: 99%
“…Demographic information for the additional subjects also appears in Table 1 (for more detailed demographic and neuropsychological information concerning the AD and Control subjects, see Chapman, Mapstone, Porsteinsson, et al, 2010). …”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations